Advanced company searchLink opens in new window

ACLARIS THERAPEUTICS INTERNATIONAL LIMITED

Company number 09691560

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Feb 2023 GAZ2 Final Gazette dissolved following liquidation
25 Nov 2022 LIQ13 Return of final meeting in a members' voluntary winding up
02 Aug 2022 LIQ03 Liquidators' statement of receipts and payments to 1 June 2022
08 Jul 2022 600 Appointment of a voluntary liquidator
08 Jul 2022 LIQ10 Removal of liquidator by court order
01 Jul 2022 AD01 Registered office address changed from 10 Fleet Place London EC4M 7QS to 10 Fleet Place London EC4M 7RB on 1 July 2022
14 Dec 2021 AD01 Registered office address changed from 15 Canada Square London E14 5GL to 10 Fleet Place London EC4M 7QS on 14 December 2021
19 Jul 2021 TM02 Termination of appointment of Oakwood Corporate Secretary Limited as a secretary on 19 July 2021
17 Jun 2021 AD01 Registered office address changed from 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom to 15 Canada Square London E14 5GL on 17 June 2021
15 Jun 2021 600 Appointment of a voluntary liquidator
15 Jun 2021 RESOLUTIONS Resolutions
  • LRESSP ‐ Special resolution to wind up on 2021-06-02
15 Jun 2021 LIQ01 Declaration of solvency
17 May 2021 CS01 Confirmation statement made on 4 May 2021 with no updates
06 May 2020 CS01 Confirmation statement made on 4 May 2020 with no updates
29 Apr 2020 AA01 Current accounting period extended from 31 December 2019 to 31 May 2020
30 Sep 2019 AA Accounts for a small company made up to 31 December 2018
14 May 2019 CS01 Confirmation statement made on 4 May 2019 with no updates
11 Dec 2018 AA Accounts for a small company made up to 31 December 2017
21 Nov 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
14 Nov 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
18 May 2018 CS01 Confirmation statement made on 4 May 2018 with no updates
18 May 2018 CH03 Secretary's details changed for Kamil Ali-Jackson on 26 January 2018
18 May 2018 CH01 Director's details changed for Frank Ruffo on 26 January 2018
18 May 2018 PSC05 Change of details for Aclaris Therapeutics, Inc. as a person with significant control on 26 January 2018
18 May 2018 CH01 Director's details changed for Neal Walker on 26 January 2018